Almirall Insists Costly Ebglyss Launch Is Progressing Well

The Spanish company's Lilly-partnered atopic dermatitis drug is enjoying a decent launch in Germany and in other European countries, "we are getting the price that we wanted," claims CEO Carlos Gallardo.

Almirall scientist
• Source: Almirall

More from Earnings

More from Therapy Areas